288 related articles for article (PubMed ID: 32759677)
1. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment.
Tang Y; Durand S; Dalle S; Caramel J
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759677
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic Balance between ZEB Family Members Is Important for Melanocyte Homeostasis and Melanoma Progression.
Bruneel K; Verstappe J; Vandamme N; Berx G
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32796736
[TBL] [Abstract][Full Text] [Related]
3. Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.
Vandamme N; Berx G
Front Oncol; 2014; 4():352. PubMed ID: 25538895
[TBL] [Abstract][Full Text] [Related]
4. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.
Denecker G; Vandamme N; Akay O; Koludrovic D; Taminau J; Lemeire K; Gheldof A; De Craene B; Van Gele M; Brochez L; Udupi GM; Rafferty M; Balint B; Gallagher WM; Ghanem G; Huylebroeck D; Haigh J; van den Oord J; Larue L; Davidson I; Marine JC; Berx G
Cell Death Differ; 2014 Aug; 21(8):1250-61. PubMed ID: 24769727
[TBL] [Abstract][Full Text] [Related]
5. The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype.
Vandamme N; Denecker G; Bruneel K; Blancke G; Akay Ö; Taminau J; De Coninck J; De Smedt E; Skrypek N; Van Loocke W; Wouters J; Nittner D; Köhler C; Darling DS; Cheng PF; Raaijmakers MIG; Levesque MP; Mallya UG; Rafferty M; Balint B; Gallagher WM; Brochez L; Huylebroeck D; Haigh JJ; Andries V; Rambow F; Van Vlierberghe P; Goossens S; van den Oord JJ; Marine JC; Berx G
Cancer Res; 2020 Jul; 80(14):2983-2995. PubMed ID: 32503808
[TBL] [Abstract][Full Text] [Related]
6. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
[TBL] [Abstract][Full Text] [Related]
7. Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis.
Pillai M; Rajaram G; Thakur P; Agarwal N; Muralidharan S; Ray A; Barbhaya D; Somarelli JA; Jolly MK
Front Oncol; 2022; 12():913803. PubMed ID: 36003764
[TBL] [Abstract][Full Text] [Related]
8. Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance.
Larribère L; Utikal J
Front Mol Neurosci; 2019; 12():111. PubMed ID: 31118886
[TBL] [Abstract][Full Text] [Related]
9. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
10. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
11. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
[TBL] [Abstract][Full Text] [Related]
12. Phenotype switching in melanoma: implications for progression and therapy.
Li FZ; Dhillon AS; Anderson RL; McArthur G; Ferrao PT
Front Oncol; 2015; 5():31. PubMed ID: 25763355
[TBL] [Abstract][Full Text] [Related]
13. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT.
Díaz-López A; Díaz-Martín J; Moreno-Bueno G; Cuevas EP; Santos V; Olmeda D; Portillo F; Palacios J; Cano A
Int J Cancer; 2015 Feb; 136(4):E62-73. PubMed ID: 25178837
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
15. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.
Kaller M; Hermeking H
Adv Exp Med Biol; 2016; 937():71-92. PubMed ID: 27573895
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
17. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
18. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance.
Wessely A; Steeb T; Berking C; Heppt MV
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071193
[TBL] [Abstract][Full Text] [Related]
19. Bone Morphogenic Protein Signaling and Melanoma.
Kraj P
Curr Treat Options Oncol; 2021 Apr; 22(6):48. PubMed ID: 33866453
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
Wan Y; Liu H; Zhang M; Huang Z; Zhou H; Zhu Y; Tao Y; Xie N; Liu X; Hou J; Wang C
Head Neck; 2020 May; 42(5):1067-1076. PubMed ID: 32048783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
